Coronary artery calcium (CAC) scans have surged in popularity over the past decade, widely marketed as a fast, accessible, and relatively inexpensive computerized tomography (CT) procedure capable of peering inside the human body to measure calcified plaque accumulation within the coronary arteries. These blood vessels supply oxygen-rich blood directly to the heart muscle, and the presence of calcification has long been interpreted as a warning sign of underlying atherosclerosis. However, a comprehensive new study conducted by researchers at Northwestern Medicine suggests that the clinical utility of these scans may be far more restricted than previously assumed. Rather than serving as a universal screening tool for all adults, the research indicates that CAC scans provide their most meaningful medical value to a remarkably specific, narrower subset of patients.
Published on August 26 in the Journal of the American Medical Association (JAMA), the study investigated whether adding a coronary artery calcium score significantly improves upon standard cardiovascular risk estimation tools. Specifically, the research team evaluated how CAC scans performed when paired with PREVENT, the American Heart Association’s newly established primary cardiovascular risk calculator. By tracking a diverse cohort of more than 6,000 adult participants over a ten-year period, the investigators discovered that for the broad general population, incorporating a calcium score yielded only a marginal improvement in predicting future heart attacks and strokes compared to using the PREVENT calculator alone.
Understanding the Mechanics: PREVENT Versus Calcium Scans
To fully grasp the implications of the Northwestern Medicine study, it is essential to understand the two distinct methodologies clinicians use to evaluate cardiovascular disease risk. Cardiovascular disease remains the leading cause of mortality in the United States, affecting roughly 10 percent of American adults aged 30 to 79. Because many of these life-threatening cardiac events are preventable, accurate risk stratification is paramount for guiding effective preventive interventions, such as the prescription of cholesterol-lowering statin medications.
The PREVENT calculator operates on clinical metrics that are routinely gathered during standard medical examinations. By analyzing a patient’s age, sex, blood pressure, cholesterol panels, and other readily available health indicators, the tool estimates an individual’s cumulative statistical probability of developing cardiovascular disease over a 10-year or 30-year horizon. It relies on population-level data and established epidemiological patterns to forecast future cardiac health without requiring specialized diagnostic imaging.
In contrast, a coronary artery calcium scan approaches risk assessment from a direct anatomical perspective. Utilizing specialized CT technology, the scan detects and quantifies deposits of calcium-containing plaque embedded in the walls of the coronary arteries. The resulting metric, commonly referred to as an Agatston score or simply a calcium score, reflects the absolute volume and density of calcified atherosclerotic disease. Standard medical consensus dictates that a higher score correlates with an elevated risk of subsequent cardiovascular morbidity.
While the intuitive appeal of visualizing actual arterial plaque is undeniable, the new research challenges the necessity of applying this imaging modality universally, highlighting that the additional diagnostic data do not always justify the routine implementation of the test.
Methodology and Chronology of the Northwestern Study
To evaluate the true predictive value of CAC scans, senior study author Dr. Nilay Shah, an assistant professor of medicine in the division of cardiology at the Northwestern University Feinberg School of Medicine, and his research colleagues examined extensive longitudinal data sourced from the landmark Multi-Ethnic Study of Atherosclerosis (MESA).
The MESA cohort provided a robust foundation for the investigation, encompassing data from more than 6,000 adult participants ranging in age from 45 to 79 years old at the study’s inception. At the baseline evaluation, every participant underwent a coronary artery calcium scan to determine their individual calcium score while simultaneously receiving a cardiovascular risk estimate calculated via the PREVENT algorithm for a 10-year period.
Following this initial baseline assessment, the researchers tracked the clinical trajectories of the participants over a decade to record actual health outcomes. During this 10-year follow-up window, approximately 6 percent of the study population experienced a definitive cardiovascular event, such as a non-fatal myocardial infarction (heart attack) or a cerebrovascular accident (stroke).
When the research team compared the predictive accuracy of the models, the results were revealing. The overall statistical improvement gained by adding the calcium score to the PREVENT calculator was modest. Specifically, the model’s discrimination—a statistical measure indicating how effectively a risk tool differentiates between individuals who will experience an event and those who will not—increased only slightly, rising from 0.73 using the PREVENT calculator alone to 0.75 when the coronary artery calcium score was factored into the equation.
The Pivotal Finding: The Borderline and Intermediate Risk Categories
Although the aggregate improvement across the entire study population was incremental, a closer examination of specific risk stratifications revealed a starkly different narrative. When the investigators narrowed their analytical focus to participants whose initial PREVENT scores placed them squarely in the borderline or intermediate risk categories—defined as individuals with an estimated 3 percent to 9 percent probability of developing heart disease over the ensuing decade—the inclusion of the calcium score proved clinically significant.
For patients falling into this ambiguous zone, the scan acted as a decisive differentiator. It provided clearer guidance regarding which individuals within the borderline demographic faced a genuinely elevated risk and which individuals had a lower risk profile than initially predicted by standard clinical metrics alone.
"For patients at borderline risk, knowing their calcium score can help determine whether their risk is actually lower or higher than initially estimated, which can help guide treatment decisions," explained Dr. Shah. In clinical practice, this precision is invaluable. It enables physicians to tailor therapeutic strategies—such as initiating statin therapy or opting for lifestyle modifications—with greater accuracy, sparing low-risk patients from unnecessary medication while ensuring high-risk individuals receive timely intervention.
Clinical Implications and Warnings Against Overuse
The findings carry profound implications for modern preventative cardiology, particularly as diagnostic imaging technologies become increasingly commercialized and accessible to the general public. Dr. Shah emphasized that the widespread availability and decreasing costs of CAC scans should not translate into indiscriminate, population-wide ordering of the tests.
"Our findings suggest that not everyone necessarily needs or would benefit from a coronary artery calcium scan for the purpose of predicting risk of heart attack and stroke," Dr. Shah noted. Furthermore, the study authors cautioned against the potential clinical downsides and financial burdens associated with the routine, uncritical use of calcium scans in patient populations where the results are unlikely to alter the course of medical management.
According to the researchers, ordering a calcium scan for individuals who already fall into a low-risk category introduces unnecessary ionizing radiation exposure, incurs additional out-of-pocket or systemic healthcare costs, and offers very little actionable clinical benefit. Conversely, deploying CAC scans in individuals who are already categorized as high risk is equally inefficient. Current clinical guidelines dictate that patients at high risk for cardiovascular disease should be prescribed a statin regimen regardless of their underlying coronary calcification status. Therefore, ordering an imaging test that will not change the therapeutic prescription regimen introduces redundant testing without shifting patient care pathways.
Validation of the PREVENT Risk Calculator
Beyond clarifying the precise role of imaging diagnostics, the Northwestern Medicine study provided robust external validation for the American Heart Association’s PREVENT risk calculator itself. The data demonstrated that the PREVENT algorithm performed exceptionally well as a standalone predictive tool, accurately forecasting cardiovascular events even when operating independently of sophisticated imaging data.
This performance reinforces the reliability of traditional clinical risk estimation models. It suggests that physicians can confidently rely on standard patient vitals and laboratory results—such as blood pressure readings and blood lipid panels—to formulate initial cardiovascular risk profiles without automatically ordering advanced imaging studies for every patient.
Future Research Directions and Limitations
While the findings offer definitive guidance on the current application of CAC scans, the research team acknowledged certain limitations within their study design that warrant further scientific inquiry. Because the MESA cohort utilized for this study primarily comprised adults between the ages of 45 and 79 at baseline, additional investigations are necessary to determine how accurately calcium scores enhance PREVENT estimates in younger demographics who have not yet reached middle age.
Additionally, Dr. Shah pointed out the imperative need to evaluate these predictive models across diverse racial and ethnic subgroups. Specifically, higher-risk populations—including South Asian and Filipino adults, who may exhibit unique cardiovascular risk factors and differing patterns of atherosclerotic plaque accumulation—require targeted studies to ensure that risk calculators and imaging guidelines apply equitably and accurately across all communities.
The study received financial backing and support from major national health institutions, including the American Heart Association (grant 24CDA1266732) and the National Heart, Lung, and Blood Institute, underscoring the high-level scientific interest in optimizing preventative cardiology practices. Alongside Dr. Shah, the Northwestern University research team included co-authors Xiaoning Huang, Lucia Petito, Norrina Allen, Dr. Philip Greenland, and Dr. Sadiya Khan.
As healthcare systems continually seek to balance diagnostic thoroughness with fiscal and biological efficiency, this study offers a clear roadmap for clinicians. By strategically reserving coronary artery calcium scans for borderline and intermediate risk patients, healthcare providers can maximize the utility of advanced medical imaging while avoiding the pitfalls of overtesting in populations where standard risk calculators already provide definitive guidance.
